Lilly Receives Emergency Use Approval for Omicron Treatment
Indianapolis-based Eli Lilly and Co. (NYSE: LLY) says it has an agreement with the U.S. government to supply up to 600,000 doses of its investigational drug bebtelovimab, an antibody therapy used for the treatment of the COVID Omicron variant. ... Read More
